Jason Ukman
Managing editor
STAT
Name |
The Obesity Revolution |
Description |
Hello, judges. Here’s how to bypass the paywall: www.statnews.com/login Username: contest@statnews.com Password: stat123 Ozempic, Wegovy, Mounjaro: a new generation of weight loss-inducing drugs is transforming patients’ lives, dividing medical experts, reshaping our concepts of health, and spurring the biggest business battle in years. In advance of clinical trial results that would show if these GLP-1 drugs also benefited the heart – a result that could send usage soaring – STAT began a series examining the rise of the drugs and their implications for society. This entry includes the most comprehensive overview of the obesity revolution; an exclusive look at tactics by Ozempic’s maker Novo Nordisk; a spellbinding tale of the science, showing these drugs act as much on the brain as on the gut; and a profile of a 9-year-old girl who epitomizes the complexity and humanity of the country’s obesity crisis. |
URLs |
|
Categories |
|
Inscribe copy |
STAT |
